financetom
Business
financetom
/
Business
/
Novo Nordisk, KKR Joint Acquisition of Sylvan Gets EU Greenlight
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Novo Nordisk, KKR Joint Acquisition of Sylvan Gets EU Greenlight
Nov 27, 2024 6:05 AM

08:30 AM EST, 11/27/2024 (MT Newswires) -- Novo Nordisk ( NVO ) and KKR's (KKR) joint acquisition of Sylvan International Biotechnology in China was cleared by the EU's antitrust review, the European Commission said Wednesday.

The Commission said it found that the proposed transaction would not raise competition concerns as the joint venture would have "negligible activities" in the European Economic Zone.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Spin Master Posts Higher Q4 Profit and Revenue, But Both Miss Target; 2025 Outlook Issued
Spin Master Posts Higher Q4 Profit and Revenue, But Both Miss Target; 2025 Outlook Issued
Feb 24, 2025
05:34 PM EST, 02/24/2025 (MT Newswires) -- Spin Master ( SNMSF ) , after trade Monday, said its fourth-quarter profit and revenue rose year-over-year, but both missed expectations. The children's toys and media company said its adjusted net income climbed to US$57.4 million, or US$0.55 per diluted share, in the period, from US$20.5 million, or US$0.19 per diluted share a...
J&J sues Samsung Bioepis over contract breach for Stelara biosimilar
J&J sues Samsung Bioepis over contract breach for Stelara biosimilar
Feb 24, 2025
(Reuters) - Johnson & Johnson ( JNJ ) said on Monday it had filed a lawsuit against Samsung Bioepis for breaching its contract agreement with the drugmaker over the launch of a biosimilar to Stelara, J&J's autoimmune drug. J&J said it is seeking a preliminary injunction for Samsung Bioepis' close copy of Stelara over an unauthorized sublicense deal with a...
Riot Platforms 2024 Swings to Profit as Revenue Rises
Riot Platforms 2024 Swings to Profit as Revenue Rises
Feb 24, 2025
05:39 PM EST, 02/24/2025 (MT Newswires) -- Riot Platforms ( RIOT ) reported late Monday its full-year 2024 swung to earnings of $0.34 per diluted share from a loss of $0.28 a year earlier. Four analysts polled by FactSet expected a loss of $0.35. Revenue for the year ended Dec. 31 was $376.7 million, up from $280.7 million a year...
Cencora Insider Sold Shares Worth $1,211,200, According to a Recent SEC Filing
Cencora Insider Sold Shares Worth $1,211,200, According to a Recent SEC Filing
Feb 24, 2025
05:33 PM EST, 02/24/2025 (MT Newswires) -- Silvana Battaglia, Executive Vice President, on February 21, 2025, sold 5,000 shares in Cencora ( COR ) for $1,211,200. Following the Form 4 filing with the SEC, Battaglia has control over a total of 15,374 common shares of the company, with 15,374 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1140859/000114085925000036/xslF345X05/wk-form4_1740435950.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved